BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1403837)

  • 1. Production of matrix metalloproteinase 2 (gelatinase/type IV collagenase) and 3 (stromelysin) by cultured oral squamous cell carcinoma.
    Kusukawa J; Sasaguri Y; Shima I; Kameyama T; Morimatsu M
    J Oral Pathol Med; 1992 May; 21(5):221-4. PubMed ID: 1403837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor.
    Shima I; Sasaguri Y; Kusukawa J; Nakano R; Yamana H; Fujita H; Kakegawa T; Morimatsu M
    Br J Cancer; 1993 Apr; 67(4):721-7. PubMed ID: 8471429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone.
    Sasaguri Y; Komiya S; Sugama K; Suzuki K; Inoue A; Morimatsu M; Nagase H
    Am J Pathol; 1992 Sep; 141(3):611-21. PubMed ID: 1519668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and identification of proteinases and proteinase inhibitors synthesized by temporomandibular joint disc cells.
    Kapila S; Lee C; Richards DW
    J Dent Res; 1995 Jun; 74(6):1328-36. PubMed ID: 7629341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
    Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
    J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
    Kubota T; Kubota E; Matsumoto A; Kawai Y; Saito H; Mikuni-Takagaki Y; Sato S
    Eur J Oral Sci; 1998 Dec; 106(6):992-8. PubMed ID: 9879910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha.
    Lefebvre V; Peeters-Joris C; Vaes G
    Biochim Biophys Acta; 1991 Aug; 1094(1):8-18. PubMed ID: 1653026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
    Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
    Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
    Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
    Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
    Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
    Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study.
    Shima I; Sasaguri Y; Kusukawa J; Yamana H; Fujita H; Kakegawa T; Morimatsu M
    Cancer; 1992 Dec; 70(12):2747-53. PubMed ID: 1451050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
    Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
    J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
    Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
    Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization.
    Miyajima Y; Nakano R; Morimatsu M
    Ann Otol Rhinol Laryngol; 1995 Sep; 104(9 Pt 1):678-84. PubMed ID: 7661515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.